The favourable effect of adding a catalase to the treatment of syndromes due to intervertebral disc degenerations.
Over a period of one year, 648 patients suffering from 4 different but very resistant syndromes due to intervertebral disc degenerations of the cervical and lumbosacral spine were treated in an identical way, but 50% of them received also catalase (Optidase¿) injections. Half of each group were males and half of them females, the age being 30--50 years. Catalase accelerates the recovery already within the first 3 weeks and the final results after 24 weeks are still significant. In addition, the study of the ischial syndrome was extended to a group of 1208 patients over a period of 5 years, confirming again the favourable effect of catalase. Catalase is generally well tolerated; dangerous reactions have not been noticed.
D000328:Adult; D002374:Catalase / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007403:Intervertebral Disc; D008297:Male; D008875:Middle Aged; D013122:Spinal Diseases / Q000188:drug therapy*
D002374:Catalase